Sana Biotechnology, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -130.78M-285.31M-355.93M
Depreciation and Depletion 1.83M5.92M11.10M15.60M24.60M17.40M
Share-based Compensation 1.50M5.83M22.36M38.34M35.53M37.68M
Deferred Taxes -7.55M
Gains from Investment Securities 48.86M52.79M40.00M21.07M-40.77M11.08M
Cash from Operations -85.52M-137.98M-251.05M-290.05M-253.58M-223.15M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 2.10M4.25M6.84M12.11M13.27M9.68M
Depreciation & Amortization (CF) 1.83M5.92M11.10M15.60M24.60M17.40M
Change in Working Capital
Change in Account Payables -0.42M1.98M-0.27M1.06M1.03M1.38M
Change in Accured Expenses 9.54M5.52M5.84M10.91M-1.52M-8.39M
Other Working Capital Changes 4.30M1.44M0.86M5.99M-8.14M3.51M
Investing Activities
Capital Expenditures 26.12M23.87M29.86M20.88M20.03M33.43M
Acquisitions 3.19M
Change in Acquisitions & Divestments 82.98M158.74M280.02M310.13M349.79M276.95M
Cash from Investing Activities -87.86M-252.56M-245.80M210.56M172.01M17.45M
Financing Activities
Cash from Financing Activities 223.74M435.69M631.75M4.91M31.65M199.75M
Additional items
Change in Cash 50.36M45.14M134.90M-74.58M-49.92M-5.95M
Free Cash Flow -111.64M-161.85M-280.92M-310.93M-273.61M-256.58M
Net Cash Flow 50.36M45.14M134.90M-74.58M-49.92M-5.95M